Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Continuous glucose monitoring and GLP-1 receptor agonists improve diabetes management, but personalized care and education are crucial.

Genetics influence opioid addiction risk, diet affects COVID-19 severity, Aerva lanata may harm kidneys, some plants fight fungi and cancer, and nursing students need better contraceptive knowledge.

Mesenchymal stem cells may help treat hair loss by improving hair cell growth and reducing inflammation.

PRP is effective for treating patchy alopecia areata.

Alopecia areata is caused by immune system issues, and JAK inhibitors might help treat it.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

JAK inhibitors show promise for treating alopecia areata, but long-term safety and emotional support are important.

Alopecia areata severity is linked to increased TH1 and TH2 activity.

Alarmin cytokines are key in controlling skin immunity and inflammation.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Intermittent compression therapy is safe and doesn't harm tissue.

Stress hormones and autoimmune reactions can cause hair loss.

Controlling cellular changes can enable safe rejuvenation without cancer risk.

Genetic discoveries are leading to new treatments for alopecia areata.

Probiotics may help manage celiac disease by improving gut health and reducing symptoms.

Combining fractionated CO2 laser with tacrolimus may help treat chronic alopecia areata.

Dr. Min's method for eyebrow and eyelash transplantation is effective, with most hairs regrowing, and proper recovery is crucial for success.

A new mouse model helps understand and find treatments for alopecia areata.

The model showed that immune system guardians and the cytokine interferon-γ are key in alopecia areata progression.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

Targeting specific T cells may help treat alopecia areata.

Vδ1+ T-cells in the skin contribute to hair loss in alopecia areata and could be targeted for treatment.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

ILC1-like cells can cause alopecia areata by themselves.

Prior infections reduced alopecia areata development in mice.

Tacrolimus effectively promotes hair regrowth in an alopecia areata mouse model.

Expanding CD4+ Tregs can stop hair loss in alopecia areata.

The humanized AA mouse model is better for testing new alopecia areata treatments.